Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

118
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
118
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

194
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
194
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

291
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
291
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

867
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
867
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

155
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

BJC reports·2026
Same author

Machine learning, whole genome sequencing, and Mendelian randomization support a role of CRP on COVID-19 severity.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

BJC reports·2026
Same author

A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors.

Journal of medicinal chemistry·2026
Same author

From comprehensive geriatric assessment to rapid bedside screening: comparing MPI and BRASS in predicting hospital outcomes in older adults - the S. Giovanni-Addolorata Hospital-SIGOT GRACE study.

BMC geriatrics·2026
Same author

Multi-parametric profiling of plasma-derived extracellular vesicles reveals a disease-associated molecular signature supporting a liquid biopsy approach in myelofibrosis.

Molecular medicine (Cambridge, Mass.)·2026
Same journal

Mangiferin alleviates metabolic-associated fatty liver disease by modulating gut microbiota and FXR signaling pathway to regulate bile acid metabolism.

Frontiers in pharmacology·2026
Same journal

The recent progression of extracellular vesicles application in osteoporosis.

Frontiers in pharmacology·2026
Same journal

Gastrodin alleviates cardiomyocyte senescence by regulating autophagy through the AMPK/mTOR/4EBP1 pathway.

Frontiers in pharmacology·2026
Same journal

Pharmacogenomic impact and genetic architecture of toxicity in pediatric acute lymphoblastic leukemia induction therapy: an exploratory modeling approach.

Frontiers in pharmacology·2026
Same journal

Efficacy and safety of huanglian wendan decoction as an adjuvant therapy for metabolic syndrome: a systematic review and meta-analysis.

Frontiers in pharmacology·2026
Same journal

Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humans.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: Sep 4, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Probabilistic Pocket Druggability Prediction via One-Class Learning.

Riccardo Aguti1,2, Erika Gardini1,2, Martina Bertazzo1

  • 1Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia, Genoa, Italy.

Frontiers in Pharmacology
|July 18, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a novel one-class approach for in silico druggability prediction, utilizing the import vector domain description (IVDD) algorithm. This method effectively identifies druggable pockets, mitigating labeling biases in drug discovery.

Keywords:
conceptrondrug designdruggability predictionimport vector domain descriptionmachine learningone-class classificationunsupervised methods

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

451

Related Experiment Videos

Last Updated: Sep 4, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

451

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Accurate in silico druggability prediction is crucial for efficient drug discovery campaigns.
  • Traditional two-class classification methods for druggability are limited by the ambiguous nature of the 'non-druggable' class.
  • A one-class approach focusing on confirmed druggable pockets offers a more robust strategy.

Purpose of the Study:

  • To propose and validate a novel one-class computational method for predicting protein target druggability.
  • To leverage the import vector domain description (IVDD) algorithm for enhanced druggability assessment.
  • To address and mitigate biases inherent in traditional druggability prediction labeling.

Main Methods:

  • Utilized the import vector domain description (IVDD), a one-class probabilistic kernel machine.
  • Employed customized DrugPred descriptors computed via NanoShaper as input features for the IVDD algorithm.
  • Applied a one-class classification strategy focusing exclusively on known druggable pockets.

Main Results:

  • Demonstrated the feasibility and effectiveness of the proposed IVDD-based one-class approach for druggability prediction.
  • Successfully mitigated biases associated with pocket labeling in computational drug discovery.
  • The method shows promise in accurately identifying druggable pockets, improving prediction reliability.

Conclusions:

  • The one-class IVDD approach provides a more appropriate and effective strategy for in silico druggability prediction compared to traditional two-class methods.
  • This method enhances the reliability of druggability assessments by focusing on unambiguous data (druggable pockets).
  • The findings support the integration of this approach into drug discovery pipelines to improve target selection and reduce bias.